BeiGene, Ltd. (BEIGF)
OTCMKTS · Delayed Price · Currency is USD
15.50
0.00 (0.00%)
At close: Sep 3, 2024

BeiGene Company Description

BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Its commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and PARTRUVIX, a selective small molecule inhibitor of PARP1 and PARP2 enzymes that is being evaluated as a monotherapy and in combinations for the treatment of various solid tumors.

The company’s clinical stage products comprise BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK‑targeting chimeric degradation activation compound active against wild‑type and mutant BTK; BGB-10188; BGB-21447, a Bcl-2 inhibitor; Ociperlimab (BGB-A1217), a TIGIT inhibitor; Zanidatamab, a bispecific HER2-targeted antibody; Surzebiclimab (BGB-A425), a TIM-3 inhibitor; BGB-A445, an OX40 agonist antibody; BGB-15025, a small molecule inhibitor of HPK1; BGB-24714, a SMAC mimetic; BGB-26808, a HPK-1 inhibitor; Lifirafenib and BGB-3245 that are inhibitors of RAF; BGB-30813; BGB-A3055, an anti-CCR8 antibody; and BGB-43395, a CDK-4 inhibitor.

It also has various preclinical programs. The company has license agreements with Ensem Therapeutics, Inc.; Shandong Luye Pharmaceutical Co., Ltd.; Shoreline Biosciences, Inc.; Nanjing Leads Biolabs, Inc.; EUSA Pharma; Assembly Biosciences, Inc.; Bio-Thera Solutions, Ltd.; Amgen Inc.; and Beijing Novartis Pharma Co., Ltd. BeiGene, Ltd. was incorporated in 2010 and is based in Camana Bay, the Cayman Islands.

BeiGene, Ltd.
Country Cayman Islands
Founded 2010
Industry Biotechnology
Sector Healthcare
Employees 10,600
CEO John Oyler

Contact Details

Address:
94 Solaris Avenue
Camana Bay, KY1-1108
Cayman Islands
Phone 345-949-4123
Website beigene.com

Stock Details

Ticker Symbol BEIGF
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
SIC Code 2836

Key Executives

Name Position
John V. Oyler Co-Founder, Executive Chairman and Chief Executive Officer
Dr. Xiaobin Wu Ph.D. President and Chief Operating Officer
Dr. Xiaodong Wang Ph.D. Co-Chairman of Scientific Advisory Board and Non-Executive Director and Co-Founder
Chan Lee General Counsel and Senior Vice President
Wang Lai Ph.D. Global Head of Research & Development
Aaron Rosenberg Chief Financial Officer and Principal Financial Officer
Titus B. Ball Vice President and Chief Accounting Officer
Liza Heapes Head of Investor Relations
Yang Ji Chief Compliance Officer
Dr. Yan Qi Senior Vice President and Head of Public Affairs - Greater China